Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) have been given an average rating of “Buy” by the twenty-four research firms that are currently covering the company. One research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is €88.31 ($93.95).

Several research analysts have issued reports on the company. Morgan Stanley set a €90.00 ($95.74) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Friday, December 9th. Warburg Research set a €85.00 ($90.43) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Thursday, October 27th. Oddo Securities set a €95.00 ($101.06) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Wednesday, November 2nd. Citigroup Inc. set a €92.00 ($97.87) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Monday, January 9th. Finally, Bankhaus Lampe set a €80.00 ($85.11) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Thursday, October 27th.

This news story was originally published by Watch List News and is the property of of Watch List News. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this news story can be accessed at http://www.watchlistnews.com/fresenius-medical-care-ag-co-kgaa-fme-receives-consensus-recommendation-of-buy-from-analysts/1121908.html.

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) opened at 76.221 on Friday. The firm has a 50-day moving average of €77.22 and a 200-day moving average of €77.50. The firm has a market capitalization of €23.33 billion and a P/E ratio of 19.906. Fresenius Medical Care AG & Co. KGaA has a one year low of €67.50 and a one year high of €85.52.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.